Initial dosing regimen of vancomycin to achieve early therapeutic plasma concentration in critically ill patients with MRSA infection based on APACHE II score-Reference-Cited by-同舟云学术

Initial dosing regimen of vancomycin to achieve early therapeutic plasma concentration in critically ill patients with MRSA infection based on APACHE II score

Published:2014-12-12 Issue:3 Volume:41 Page:211-218
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Imaura Masaharu,Yokoyama Haruko,Kohata Yuji,Kanai Riichiro,Kohyama Tomoki,Idemitsu Wataru,Maki Yuichi,Igarashi Takashi,Takahashi Hiroyuki,Kanno Hiroshi,Yamada Yasuhiko

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13318-014-0246-1.pdf

Reference19 articles.

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655. doi: 10.1378/chest.101.6.1644

2. Damas P, Canivet JL, de Groote D, Vrindts Y, Albert A, Franchimont P, Lamy M (1997) Sepsis and serum cytokine concentrations. Crit Care Med 25:405–412. doi: 10.1097/00003246-199703000-00006

3. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155. doi: 10.1378/chest.118.1.146

4. Joukhadar C, Frossard M, Mayer BX, Brunner M, Klein N, Siostrzonek P, Eichler HG, Müller M (2001) Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 29:385–391. doi: 10.1097/00003246-200102000-00030

5. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829. doi: 10.1097/00003246-198510000-00009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of teicoplanin plasma concentration in critically ill patients: a combination of machine learning and population pharmacokinetics;Journal of Antimicrobial Chemotherapy;2024-08-29

2. Initial Serum C-reactive Protein Level as a Predictor of Increasing Serum Vancomycin Concentration During Treatment;Therapeutic Drug Monitoring;2021-10

3. Association Between Pathophysiology and Volume of Distribution Among Patients With Sepsis or Septic Shock Treated With Imipenem: A Prospective Cohort Study;The Journal of Infectious Diseases;2020-03-16

4. SOFA score is superior to APACHE-II score in predicting the prognosis of critically ill patients with acute kidney injury undergoing continuous renal replacement therapy;Renal Failure;2020-01-01

5. Individualized Pharmacokinetic Dosing of Vancomycin Reduces Time to Therapeutic Trough Concentrations in Critically Ill Patients;The Journal of Clinical Pharmacology;2018-06-29